Claire Leurent
Private Equity Investor chez AbbVie Ventures LLC
Profil
Claire Leurent is currently a Managing Director at AbbVie Ventures LLC.
Previously, she worked as a Managing Director at Samsung Catalyst from 2018 to 2019 and as a Principal at Johnson & Johnson Innovation - JJDC, Inc. from 2019 to 2023.
She also served as a Project Manager at FORENAP Pharma SARL.
Dr. Leurent holds a doctorate from the Institute of Genetics, Molecular & Cellular Biology and an MBA from MIT Sloan School of Management, which she obtained in 2016.
Postes actifs de Claire Leurent
| Sociétés | Poste | Début |
|---|---|---|
AbbVie Ventures LLC
 AbbVie Ventures LLC Investment ManagersFinance AbbVie Ventures LLC (AbbVie Ventures) is a venture capital firm, a subsidiary of AbbVie, Inc. founded in 2009. The firm is headquartered in North Chicago, Illinois. | Private Equity Investor | 01/01/2024 |
Anciens postes connus de Claire Leurent
| Sociétés | Poste | Fin |
|---|---|---|
Johnson & Johnson Innovation - JJDC, Inc.
 Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Private Equity Investor | 01/01/2023 |
Samsung Catalyst
 Samsung Catalyst Investment ManagersFinance Samsung Catalyst (Samsung Catalyst) is a venture capital subsidiary of Samsung Venture Investment Corp founded in 2004. The firm is headquartered in Menlo Park, California. | Private Equity Investor | 01/12/2019 |
FORENAP Pharma SARL
 FORENAP Pharma SARL Miscellaneous Commercial ServicesCommercial Services Located in Alsace, in the heart of Europe, Forenap Pharma is an International Contract Research Organization (CRO) combined with a 'Site Management Organization' (SMO) specialized in early Drug Development and Research in Neuroscience. Founded in 1986, FORENAP has succeeded in developing in the past 20 years a unique expertise in Central Nervous System. It currently employs 180 people. FORENAP Group is made of two main lines of skills: FORENAP Pharma: preclinical and clinical studies management as well as related business activities; FORENAP FRP: dedicated to scientific research. FORENAP proposes optimized development plans and ensures the management of preclinical, Phase I (in all therapeutic areas) and Phase II (for Central Nervous System and Cardiovascular compounds) studies. With its own 72-bed centre. FORENAP offers a 'full services package' (including 'consulting' services) to bring customers projects to success, from Drug Discovery to Marketing authorization. | Corporate Officer/Principal | - |
Formation de Claire Leurent
| MIT Sloan School of Management | Masters Business Admin |
| Institute of Genetics, Molecular & Cellular Biology | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Johnson & Johnson Innovation - JJDC, Inc.
Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Finance |
Samsung Catalyst
Samsung Catalyst Investment ManagersFinance Samsung Catalyst (Samsung Catalyst) is a venture capital subsidiary of Samsung Venture Investment Corp founded in 2004. The firm is headquartered in Menlo Park, California. | Finance |
FORENAP Pharma SARL
FORENAP Pharma SARL Miscellaneous Commercial ServicesCommercial Services Located in Alsace, in the heart of Europe, Forenap Pharma is an International Contract Research Organization (CRO) combined with a 'Site Management Organization' (SMO) specialized in early Drug Development and Research in Neuroscience. Founded in 1986, FORENAP has succeeded in developing in the past 20 years a unique expertise in Central Nervous System. It currently employs 180 people. FORENAP Group is made of two main lines of skills: FORENAP Pharma: preclinical and clinical studies management as well as related business activities; FORENAP FRP: dedicated to scientific research. FORENAP proposes optimized development plans and ensures the management of preclinical, Phase I (in all therapeutic areas) and Phase II (for Central Nervous System and Cardiovascular compounds) studies. With its own 72-bed centre. FORENAP offers a 'full services package' (including 'consulting' services) to bring customers projects to success, from Drug Discovery to Marketing authorization. | Commercial Services |
AbbVie Ventures LLC
AbbVie Ventures LLC Investment ManagersFinance AbbVie Ventures LLC (AbbVie Ventures) is a venture capital firm, a subsidiary of AbbVie, Inc. founded in 2009. The firm is headquartered in North Chicago, Illinois. | Finance |
